BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)

Stock · NASDAQ · Health Care

$0.9558as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

BCTXL
BriaCell Therapeutics Corp. Warrant expiring 2031
$0.9558
▲ 2.79%
Market cap $8.00MP/E —
ADIL
Adial Pharmaceuticals Inc Common Stock
$5.6
▼ 1.41%
Market cap $7.80MP/E —
$1.31$249.81
SNGX
Soligenix Inc. Common Stock
$0.38
▲ 0.00%
Market cap $8.22MP/E —
$0.28$3.22
MTVA
MetaVia Inc. Common Stock
$1.71
▲ 3.01%
Market cap $7.64MP/E —
$0.9661$19.03
CNSP
CNS Pharmaceuticals Inc. Common Stock
$5.52
▲ 0.11%
Market cap $8.46MP/E —
$1.9$10.59
APRE
Aprea Therapeutics Inc. Common stock
$0.8387
▼ 2.48%
Market cap $7.40MP/E —
$0.548$1.69
APUS
Apimeds Pharmaceuticals US Inc. Common Stock
$3.87
▼ 1.28%
Market cap $7.32MP/E —
$3.39$403.1

Symbol	Market cap	P/E ratio	Price	1D	52-week range
BCTXL BriaCell Therapeutics Corp. Warrant expiring 2031	$8.00M	—	$0.9558	▲ 2.79%
ADIL Adial Pharmaceuticals Inc Common Stock	$7.80M	—	$5.6	▼ 1.41%	$1.31$249.81
SNGX Soligenix Inc. Common Stock	$8.22M	—	$0.38	▲ 0.00%	$0.28$3.22
MTVA MetaVia Inc. Common Stock	$7.64M	—	$1.71	▲ 3.01%	$0.9661$19.03
CNSP CNS Pharmaceuticals Inc. Common Stock	$8.46M	—	$5.52	▲ 0.11%	$1.9$10.59
APRE Aprea Therapeutics Inc. Common stock	$7.40M	—	$0.8387	▼ 2.48%	$0.548$1.69
APUS Apimeds Pharmaceuticals US Inc. Common Stock	$7.32M	—	$3.87	▼ 1.28%	$3.39$403.1

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.